BioSpace News Archive

Ideal Image MedSpa, the nation’s leading MedSpa specializing in non-surgical aesthetic treatments, launched CoolTone, the latest innovation in body shaping technology.

Hackensack Meridian Hackensack University Medical Center announced that it is the first hospital in the nation to successfully implant the world’s first heart failure neuromodulation device, BAROSTIM NEO™.

Applied BioMath, the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced a collaboration with Gritstone Oncology, Inc. for semi-mechanistic systems pharmacology modeling.

The Partnership to Fight Chronic Disease has released the following statement on the proposed international pricing index

Cerevance, a clinical stage biopharmaceutical company advancing new medicines for brain diseases, today announced the company will present at the BIO CEO & Investor Conference, taking place in New York, Feb. 10 – 11, 2020.

The U.S. Food and Drug Administration and the Federal Trade Commission today signed a joint statement regarding enhanced collaboration in support of a robust marketplace for biological products, including the critical adoption of biosimilars and interchangeable products.

Acoer, developer of blockchain-enabled applications, announced that it is helping its healthcare and life sciences clients to easily track and visualize the Coronavirus outbreak with its HashLog data visualization engine.

Anritsu Instruments Supporting 3G/4G/5G and Wi-Fi to be Used by Eurofins E&E to Ensure Performance, Compatibility, and Compliance of Wireless and Radio Devices

United Health Products, Inc. announced that four surgeons who participated in the recently completed human clinical trial for HemoStyp have prepared and submitted an article entitled Efficacy and Safety of HemoStyp as an Adjunct for Management of Secondary Hemostasis in the Operative Setting to the American Journal of Surgery for peer review.

Dicerna™ Pharmaceuticals, Inc. announced that the Compensation Committee of the Company’s Board of Directors approved inducement grants of stock options to purchase a total of 159,700 shares of common stock and 45,500 restricted stock units to be distributed among 15 new employees, with a grant date of February 3, 2020.